Neil Kumar, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Neil Kumar, Ph.D.
Neil Kumar, Ph.D. is recorded as Chairman at BridgeBio Oncology Therapeutics, Inc. (BBOT). BridgeBio Oncology Therapeutics, Inc. reported in an 8-K filed April 23, 2026 that Neil Kumar, Ph.D. was appointed Executive Chairman of the Board, effective April 20, 2026.
“On April 20, 2026, the Board appointed Neil Kumar, Ph.D., as Executive Chairman of the Board, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-04-20–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at BridgeBio Oncology Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Eli Wallace CEO, Board Member
- Pedro Beltran, Ph.D. CEO, Board Member
- Pedro J. Beltran, Ph.D. CEO, Board Member
- Idan Elmelech CFO, COO
- Uneek Mehra CFO
- Marc Cobo Chief Accounting Officer
- Albert A. Holman, III Board Member
- Bihua Chen Board Member
- Frank McCormick Board Member
- Frank P. McCormick Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.